JP2002302416A - Fat synthesis-accelerating agent and cosmetic - Google Patents

Fat synthesis-accelerating agent and cosmetic

Info

Publication number
JP2002302416A
JP2002302416A JP2001137981A JP2001137981A JP2002302416A JP 2002302416 A JP2002302416 A JP 2002302416A JP 2001137981 A JP2001137981 A JP 2001137981A JP 2001137981 A JP2001137981 A JP 2001137981A JP 2002302416 A JP2002302416 A JP 2002302416A
Authority
JP
Japan
Prior art keywords
fat synthesis
cosmetic
various
extracts
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001137981A
Other languages
Japanese (ja)
Other versions
JP4611565B2 (en
JP2002302416A5 (en
Inventor
Mikito Ihara
幹人 伊原
Tomohiro Terauchi
友広 寺内
Kazuhiro Suetsugu
一博 末次
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Naris Cosmetics Co Ltd
Original Assignee
Naris Cosmetics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naris Cosmetics Co Ltd filed Critical Naris Cosmetics Co Ltd
Priority to JP2001137981A priority Critical patent/JP4611565B2/en
Publication of JP2002302416A publication Critical patent/JP2002302416A/en
Publication of JP2002302416A5 publication Critical patent/JP2002302416A5/ja
Application granted granted Critical
Publication of JP4611565B2 publication Critical patent/JP4611565B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a fat synthesis-accelerating agent and to prepare a cosmetic each being incorporated with a useful plant extract liquid having the fat synthesis-accelerating effect as recognized in each of various extracts from each of various plants as an active ingredient. SOLUTION: The excellent fat synthesis-accelerating agent and the cosmetic based on the fat synthesis-accelerating effect of each of the various extracts from each of the various plants are provided. Also, since the above fat synthesis- accelerating agent is a natural product contained in each of the various extracts from each of the various plants, it is safe and is also stable to heat, has less adverse effect and can open up uses widely by exhibiting a marked effect not only in the cosmetic field such as the above cosmetic, but also in each of various technological fields such as a medicine and food.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、各植物の各種抽出物を
有効成分とした脂肪合成促進効果有することを特徴とす
る脂肪合成促進剤および化粧料に関するものである。特
に、本発明にかかる化粧料は、女性らしい「ふっくら」
した輪郭の形成、乳房の豊胸用化粧料の提供を主たる目
的とするものであるが、さらには、本発明の利用分野は
前記化粧料の化粧品分野にとどまるものではなく、医薬
品および食品等々の各種技術分野にも広く応用できるも
のである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a fat synthesis promoting agent and a cosmetic, which have an effect of promoting fat synthesis using various extracts of various plants as active ingredients. In particular, the cosmetics according to the present invention are feminine "fluffy"
The purpose of the present invention is mainly to provide a cosmetic for breast augmentation of breasts, but the field of application of the present invention is not limited to the cosmetics field of the cosmetics, such as pharmaceuticals and foods. It can be widely applied to various technical fields.

【0002】[0002]

【従来の技術および発明が解決しようとする課題】近
年、ダイエットを中心とした健康志向が各方面でクロー
ズアップされてきており、特に女性にとって、美しく痩
せていることは永遠の望みにもなっている。当然のこと
ながら、化粧品分野でもこの点に関心が深まり、これま
で様々なスリミング製品が店頭に並んできた。
2. Description of the Related Art In recent years, health consciousness centering on diet has been increasing in various fields, and beautiful and thinness has become an eternal desire especially for women. I have. Not surprisingly, interest in this aspect has grown in the cosmetics field, and a variety of slimming products have hit the shelves.

【0003】その反面で「女性らしさを保ちたい」とい
う点から、逆に頬骨の下や目の下、顔のくぼみ等を「ふ
っくら」させたり、女性の美の象徴とも言える乳房を豊
胸したいという願望もある。その背景には、美しくバラ
ンスのとれた体型へと女性達の願望がある。
[0003] On the other hand, from the point of "want to maintain femininity", on the other hand, the desire to "puffy" the underside of the cheekbones, under the eyes, the depression of the face, etc., and to augment the breast, which is a symbol of female beauty There is also. Behind this is the desire of women to be beautifully balanced.

【0004】一般的に「ふっくら」させる方法として、
皮膚真皮細胞外マトリックスにおけるコラーゲン(膠原
線維)やエラスチン(弾力線維)の代謝を改善する方法
もあるが効果的でなく、むしろ、「ふっくら」させる要
因の大半を占める脂肪組織の増大および蓄積が最も有効
的で直接的であると考える。
[0004] In general, as a method of making "fluffy",
There are ways to improve the metabolism of collagen (elastin) and collagen (elastin) in the dermal extracellular matrix, but they are not effective, but rather increase and accumulate adipose tissue, which accounts for most of the "plumping" factors. Think effective and direct.

【0005】また、脂肪組織の増大及び蓄積は、組織を
構成する脂肪細胞が脂肪を合成することによってなされ
るが、頬骨の下や目の下、顔のくぼみや乳房では、下腿
部などと比較して脂肪合成作用が低く、脂肪分解作用が
高い特徴があり、女性らしい「ふっくら」した輪郭の形
成、乳房の豊胸には、この脂肪細胞における脂肪合成を
促進させ、脂肪組織の増大及び蓄積を促すことが必要で
ある。しかしながら、これらを解決する脂肪合成促進剤
および化粧料は、これまで見い出されていなかった。
[0005] In addition, fat tissue is increased and accumulated by the fat cells constituting the tissue, which synthesize fat. However, the fat cells under the cheekbones, under the eyes, in the hollows of the face and the breast, are compared with the lower legs. It has a low fat synthesis effect and a high lipolysis effect, and the formation of a feminine "fluffy" contour, breast augmentation promotes fat synthesis in these adipocytes and increases and accumulates adipose tissue. It is necessary to encourage. However, fat synthesis promoters and cosmetics that solve these problems have not been found so far.

【0006】以上のことから、女性らしい「ふっくら」
した輪郭の形成、頬骨の下や目の下、顔のくぼみや乳房
等の脂肪細胞における脂肪合成を促進させ、脂肪組織の
増大及び蓄積を促す脂肪合成促進剤および化粧料が望ま
れていた。
From the above, the feminine "fluffy"
There has been a demand for a fat synthesis promoter and a cosmetic that promote the formation of a contour, a fat synthesis in fat cells such as under the cheekbone and under the eyes, a depression in the face and a breast, and promote an increase and accumulation of adipose tissue.

【0007】[0007]

【課題を解決するための手段】そこで、発明者らは、上
記課題に鑑み鋭意検討を重ねた結果、種々の植物の抽出
物に脂肪合成促進効果を有することを見い出した。
Means for Solving the Problems In view of the above problems, the present inventors have conducted intensive studies, and as a result, have found that extracts of various plants have an effect of promoting fat synthesis.

【0008】すなわち、本発明は、カワカワ(Pipe
r methysticum Forst.)、クマツ
ヅラ(Verbena officinalis
L.)、コハコベ(Stellaria media
(L.)Vill.)、セイヨウタンポポ(Tarax
acum officinale Weber,Tar
axacum sect.Ruderalia spe
cies)、セイヨウナツユキソウ(Filipend
ura ulmaria(L.)Maxim.)、ヒマ
ワリ(Helianthus annuus L.)、
マヨラナ(Origanum majorana
L.)、ムラサキツメクサ(Trifoliumpra
tense L.)、ラタニィ(Krameria t
riandraRuiz et Par.)、ラレア
(Larrea tridentata,Larrea
mexicana)から選択される1種又は2種以上
の植物の抽出物が副作用も無く安全で、且安定な脂肪合
成促進剤効果を有すること見い出し、それらの有効成分
を含有することを特徴とする脂肪合成促進剤および化粧
料を提供することある。
That is, the present invention relates to Kawakawa (Pipe
r methodicum Forst. ), Versicolora (Verbena officinalis)
L. ), Kohakobe (Stellaria media)
(L.) Vill. ), Dandelion (Tarax)
acum officinale Weber, Tar
axacum sec. Ruderalia spe
ces), Ficus pumila (Filipend)
ura ulmaria (L.) Maxim. ), Sunflower (Helianthus annuus L.),
Majorana (Origanum majorana)
L. ), Purple clover (Trifolimpra)
tense L. ), Rattanii (Krameriat)
riandra Ruiz et Par. ), Larea (Larrea tridentata, Larrea)
one or more plant extracts selected from M. mexicana), which are safe without side effects and have a stable effect of promoting fat synthesis, and fats containing these active ingredients. May provide synthesis accelerators and cosmetics.

【0009】[0009]

【発明の実施の形態】以下、本発明を詳述する。本発明
で使用する「カワカワ(Piper methysti
cum Forst.)」は、Polynesia産コ
ショウ科(Piperaceae)の灌木で、一般にカ
ワカワと呼ばれている植物全てを用いることができる。
DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below in detail. "Kawakawa (Piper methisti)" used in the present invention
cum Forst. ")" Is a shrub of the family Pepperaceae from Polynesia, and all plants commonly referred to as Kawakawa can be used.

【0010】本発明で使用する「クマツヅラ(Verb
ena officinalisL.)」は、クマツヅ
ラ科(Verbenaceae)の薬草(Herbs)
で、一般にクマツヅラと呼ばれている植物全てを用いる
ことができる。
[0010] As used in the present invention,
ena officinalis L. ) "Is a medicinal herb (Herbs) of the family Verbenaceae.
Thus, all the plants commonly referred to as black pine can be used.

【0011】本発明で使用する「コハコベ(Stell
aria media(L.)Vill.)」は、ナデ
シコ科(Caryophyllaceae)の薬草(H
erbs)で、一般にハコベと呼ばれている植物全てを
用いることができる。
In the present invention, "Kohakobe (Stell)" is used.
aria media (L.) Vill. ) "Is a herb of Caryophyllaceae (H)
erbs), all plants commonly called chickweed can be used.

【0012】本発明で使用する「セイヨウタンポポ(T
araxacum officinale Webe
r,Taraxacumsect.Ruderalia
species)」は、キク科(Rosaceae)
の薬草(Herbs)で、一般にタンポポと呼ばれてい
る植物全てを用いることができる。
The dandelion (T) used in the present invention
araxacum officinale web
r, Taraxacumsect. Ruderalia
Species) ”is a kind of Asteraceae (Rosaceae)
Herbs, and all plants commonly called dandelions can be used.

【0013】本発明で使用する「セイヨウナツユキソウ
(Filipendura ulmaria(L.)M
axim.)」は、バラ科(Rosaceae)の薬草
(Herbs)で、一般にセイヨウナツユキソウと呼ば
れている植物全てを用いることができる。
[0013] As used in the present invention, “Filipendula ulmaria (L.) M
axim. ")" Is a medicinal herb (Herbs) of the family Rosaceae, and all plants commonly referred to as eucalyptus can be used.

【0014】本発明で使用する「ヒマワリ(Helia
nthus annuus L.)」は、キク科(Co
mpositae)の薬草(Herbs)で、一般にヒ
マワリと呼ばれている植物全てを用いることができる。
[0014] The "sunflower" (Helia) used in the present invention.
nthus annuus L .; ) "Means Asteraceae (Co
All of the plants commonly referred to as sunflowers can be used.

【0015】本発明で使用する「マヨラナ(Origa
num majorana L.)」は、シソ科(La
biatae)の薬草(Herbs)で、一般にマヨラ
ナと呼ばれている植物全てを用いることができる。
[0015] The "Majorana" (Origa) used in the present invention is used.
num majorana L .; ) "Means the Labiatae (La)
All of the plants commonly referred to as Majorana can be used as the herb (Biatae).

【0016】本発明で使用する「ムラサキツメクサ(T
rifolium pratense L.)」は、マ
メ科(Leguminosae)の薬草(Herbs)
で、一般にツメクサと呼ばれている植物全てを用いるこ
とができる。
The "red clover" (T) used in the present invention
rifolium platenense L. ) "Is a herb of Leguminosae (Herbs)
Thus, all plants generally called clovergrass can be used.

【0017】本発明で使用する「ラタニィ(Krame
ria triandra Ruiz et Pa
r.)」は、南米産マメ科(Leguminosae)
の小灌木で、一般にラタニィと呼ばれている植物全てを
用いることができる。
In the present invention, "Lattany (Krame)" is used.
ria triandra Ruiz et Pa
r. ) "Means legumes from South America (Leguminosae)
In the small shrub, all plants commonly called rattany can be used.

【0018】本発明で使用する「ラレア(Larrea
tridentata,Larrea mexica
na)」は、北メキシコ(Arizonaなど)産マビ
シ科(Zygophyllaceae)の常緑灌木で、
一般にラレアと呼ばれている植物全てを用いることがで
きる。
As used in the present invention, "Larrea"
tridentata, Larrea mexica
na) "is an evergreen shrub of Zygophyllaceae from northern Mexico (such as Arizona),
All plants commonly called larea can be used.

【0019】また、各植物の各種抽出物は、各植物の
花、全草またはその葉、枝、樹皮、根等の一部又は全て
の箇所(以下「原体」と称する)を乾燥し、又は乾燥す
ることなく粉砕した後、水および/又はメタノール、エ
タノール、プロパノール等の低級アルコール又は低級ア
ルコール水溶液、プロピレングリコール、1.3−ブチ
レングリコール、グリセリン等の多価アルコール又は多
価アルコール水溶液を単独および/又は2種類以上の溶
媒を任意に組み合わせて使用することができる。
In addition, various extracts of each plant are obtained by drying some or all of the flowers, whole plants or their leaves, branches, bark, roots, etc. Or, after pulverization without drying, water and / or a lower alcohol or an aqueous solution of a lower alcohol such as methanol, ethanol, or propanol, or a polyhydric alcohol or an aqueous solution of a polyhydric alcohol such as propylene glycol, 1.3-butylene glycol, or glycerin are used alone. And / or two or more solvents can be used in any combination.

【0020】各植物の低級アルコールによる抽出液は、
ソックスレー抽出器を用いて抽出液を得ることができ
る。そして、各種植物抽出物は、低級アルコール、各種
有機溶媒又は有機溶媒水溶液抽出液については各々低級
アルコール、有機溶媒を留去して減圧濃縮し、また、水
抽出物についてはその抽出液を減圧濃縮した後、凍結乾
燥して、それぞれの抽出物を得ることができる。なお、
具体的な各種植物抽出物の調製例は、実施例の項におい
て詳述する。
The extract of each plant with lower alcohol is as follows:
An extract can be obtained using a Soxhlet extractor. For various plant extracts, lower alcohols, various organic solvents or organic solvent aqueous extracts are concentrated by distillation by removing the lower alcohols and organic solvents, respectively, and for water extracts, the extracts are concentrated under reduced pressure. After that, each extract can be obtained by freeze-drying. In addition,
Specific examples of the preparation of various plant extracts will be described in detail in Examples.

【0021】本発明にかかる脂肪合成促進剤における各
種有効成分(各植物の各種抽出物)の配合量(含有量)
は、前記有効成分の種類及びその組合せ、ならびにその
使用目的、態様、使用形態、使用回数等々に応じて変動
させることができるので、特に限定されない。原則的に
は、有効量存在すればよいことになるが、一般的には脂
肪合成促進剤の各組成物に対して0.0001〜100
重量%、好ましくは1〜10重量%が利用できる。さら
にまた、本発明にかかる有効成分(各植物の各種抽出
物)は1種類でも作用効果を発揮することができるが、
2種類以上の有効成分を適宜組み合わせて利用すること
より、優れた相乗効果を奏することが期待できる。
The amount (content) of various active ingredients (various extracts of each plant) in the fat synthesis promoter according to the present invention.
Is not particularly limited because it can be varied according to the kind of the active ingredient and the combination thereof, the purpose of use, the mode, the use form, the number of uses, and the like. In principle, it is sufficient that an effective amount is present, but generally 0.0001 to 100 for each composition of the fat synthesis promoter.
%, Preferably 1 to 10% by weight is available. Furthermore, although the active ingredient (various extracts of each plant) according to the present invention can exert an effect even by one kind,
By using two or more kinds of active ingredients in appropriate combination, an excellent synergistic effect can be expected.

【0022】本発明にかかる各植物の各種抽出物に関す
る脂肪合成促進効果の測定は、次の方法に実施した。
The measurement of the fat synthesis-promoting effect of various extracts of each plant according to the present invention was carried out by the following method.

【0023】脂肪合成促進効果は、脂肪細胞前駆細胞株
(マウス3T3−L1:大日本製薬製)を用い測定し
た。すなわち、脂肪細胞中のトリグリセライド(中性脂
肪)をイソプロパノールで抽出した後、アセチルアセト
ンを用いて定量し、それぞれ有効成分の有無の検索を行
った。なお、具体的な測定方法および脂肪合成促進率
(%)の算出方法は、実施例の項において詳述する。
The effect of promoting fat synthesis was measured using an adipocyte precursor cell line (mouse 3T3-L1: manufactured by Dainippon Pharmaceutical). That is, triglycerides (neutral fats) in adipocytes were extracted with isopropanol, quantified using acetylacetone, and searched for the presence or absence of an active ingredient. The specific measurement method and the method of calculating the fat synthesis promotion rate (%) will be described in detail in the Examples section.

【0024】脂肪組織の増大、蓄積は、組織を構成する
脂肪細胞が脂肪を合成することによってなされるが、頬
骨の下や目の下、顔のくぼみや乳房では、下腿部などと
比較して脂肪合成作用が低く、脂肪分解作用が高い特徴
があり、女性らしい「ふっくら」した輪郭の形成、乳房
の豊胸には、この脂肪細胞における脂肪合成を促進さ
せ、脂肪組織の増大及び蓄積を促すことが必要である。
したがって、脂肪合成を促進させることは、女性らしい
「ふっくら」した輪郭を形成、乳房を豊胸させる手段と
して重要である。また、本発明にかかる脂肪合成促進剤
は各植物の各種抽出物に存在するものであり、極めて優
れた脂肪合成促進効果を有し、しかも安定な特性を有す
るものである。従って、本発明にかかる脂肪合成促進剤
効果を有する各種植物抽出物は、医薬品および食品等々
の産業分野に利用が可能である。
The increase and accumulation of adipose tissue is achieved by the synthesis of fat by the fat cells constituting the tissue. Featuring a low synthetic effect and high lipolytic action, the formation of a feminine "fluffy" contour, breast augmentation promotes fat synthesis in these adipocytes and promotes the growth and accumulation of adipose tissue is necessary.
Therefore, promoting fat synthesis is important as a means of forming a feminine “fluffy” contour and breast augmentation. In addition, the fat synthesis promoter according to the present invention is present in various extracts of each plant, has an extremely excellent fat synthesis promotion effect, and has stable properties. Therefore, the various plant extracts having the effect of promoting fat synthesis according to the present invention can be used in industrial fields such as pharmaceuticals and foods.

【0025】すなわち、本発明にかかる脂肪合成促進剤
および化粧料は、カワカワ(Piper methys
ticum Forst.)、クマツヅラ(Verbe
naofficinalis L.)、コハコベ(St
ellaria media(L.)Vill.)、セ
イヨウタンポポ(Taraxacum officin
ale Weber,Taraxcacum sec
t.Ruderalia species)、セイヨウ
ナツユキソウ(Filipendura ulmari
a(L.)Maxim.)、ヒマワリ(Heliant
hus annuus L.)、マヨラナ(Origa
num majorana L.)、ムラサキツメクサ
(Trifolium pratense L.)、ラ
タニィ(Krameria triandra Rui
z et Par.)、ラレア(Larrea tri
dentata,Larrea mexicana)か
ら選択される1種又は2種以上の植物の抽出物を含有し
てなる脂肪合成促効果を特徴とするものである。
That is, the fat synthesis promoter and the cosmetic according to the present invention are prepared from Kawakawa (Piper methys).
ticum Forst. ), Kumatsudura (Verbe)
naofficinalis L .; ), Kohakobe (St
ellaria media (L.) Vill. ), Taraxacum officin
ale Weber, Taraxcacum sec
t. Ruderaria species), Filippodia ulmari (Filipendura ulmari)
a (L.) Maxim. ), Sunflower (Heliant)
hus annuus L .; ), Majorana (Origa
num majorana L .; ), Trifolium platenense L., Ratani (Krameria triandra Rui)
z et Par. ), Larrea tri
dentata, Larrea mexicana), characterized by a fat synthesis promoting effect comprising an extract of one or more plants selected from the group consisting of:

【0026】例えば、本発明にかかる各種有効成分の1
種又は2種以上を各種化粧料基剤等で配合して、クリー
ム、乳液、化粧水、パック剤、洗顔料などの各種基礎化
粧料、ファンデーション、ほほ紅、口紅、白粉などの各
種メーキャップ料、石鹸、オーデコロンなど、その他化
粧料に対して広範囲に適用できる。また、前記各種化粧
料の態様は、溶液、エマルジョン、軟膏、オイル、ワッ
クス、ゾル、ゲル、パウダー、スプレーなどの各種態様
で適用できる。
For example, one of the various active ingredients according to the present invention
Seeds or two or more kinds are blended with various cosmetic bases and the like, and various basic cosmetics such as creams, emulsions, lotions, packs, face wash, foundations, various make-ups such as blush, lipstick, white powder, It can be widely applied to other cosmetics such as soap and cologne. In addition, the above-mentioned various aspects of cosmetics can be applied in various aspects such as solutions, emulsions, ointments, oils, waxes, sols, gels, powders, and sprays.

【0027】[0027]

【作用】本発明にかかる各植物の各種抽出物は、前述の
とおり、副作用が無く安全でしかも安定な脂肪合成促進
剤の1種または2種以上を有効成分として含有する化粧
料を提供することができるため、よって女性らしい「ふ
っくら」した輪郭の形成、とりわけ乳房の豊胸を達成で
きる。
As described above, various extracts of each plant according to the present invention provide a cosmetic composition containing one or more kinds of safe and stable fat synthesis promoters without side effects as active ingredients. Therefore, it is possible to achieve a feminine “plump” contour, especially breast augmentation.

【0028】[0028]

【実施例】次に、実施例により本発明をさらに詳細に説
明するが、本発明はこれらの実施例により制限されるも
のではない。なお、実施例中の部は、特に断りのない限
り重量部を示す。
EXAMPLES Next, the present invention will be described in more detail by way of examples, but the present invention is not limited to these examples. In addition, the part in an Example shows a weight part unless there is particular notice.

【0029】1.各種植物抽出物の調製例 (1)調製例1(水抽出物):前記各植物の原体2〜5
gを円筒濾紙に入れ、イオン交換水50〜100mlに
浸し、60℃で8時間加熱抽出してロ液を得た。この操
作を3回繰り返し、全てのロ液を合せて凍結乾燥して各
植物の水抽出物を得た。 (2)調製例2(各種低級アルコール抽出物):抽出溶
媒に各種低級アルコールを用い、ソックスレー抽出器を
用いて8時間抽出した後、溶媒を留去、抽出物を粉末に
して各植物の各種低級アルコール抽出物を得た。 (3)調製例3(各種有機溶媒または有機溶媒水溶液抽
出物):前記水抽出物における抽出操作において、水の
代わりに各種有機溶媒または有機溶媒水溶液を使用し
た。全ての抽出液を合せて可能な限り溶媒を留去、濃縮
した後、凍結乾燥して各植物の各種有機溶媒または有機
溶媒水溶液抽出物を得た。
1. Preparation Examples of Various Plant Extracts (1) Preparation Example 1 (Water Extract): Active Substances 2 to 5 of Each Plant
g was placed in a cylindrical filter paper, immersed in 50 to 100 ml of ion-exchanged water, and heated and extracted at 60 ° C. for 8 hours to obtain a filtrate. This operation was repeated three times, and all the liquids were combined and freeze-dried to obtain a water extract of each plant. (2) Preparation Example 2 (Various lower alcohol extracts): After extracting various lower alcohols for 8 hours using a Soxhlet extractor, the solvent was distilled off, and the extract was powdered to obtain various extracts of each plant. A lower alcohol extract was obtained. (3) Preparation Example 3 (extract of various organic solvents or organic solvent aqueous solution): In the extraction operation of the water extract, various organic solvents or organic solvent aqueous solutions were used instead of water. All extracts were combined, the solvent was distilled off as much as possible, concentrated, and then lyophilized to obtain extracts of various organic solvents or aqueous organic solvent of each plant.

【0030】2.脂肪合成促進効果の測定方法 まず、(1)10容量%CS含有DMEM培地、(2)
分化誘導培地を調製する。 (1)10容量%CS含有DMEM培地:DMEM培地
(IBC Biomedicals社製)13.48g
に蒸留水1L加え、それぞれ終濃度10容量%CS(C
ALF BOVINE SERUM)、0.1重量%炭
酸水素ナトリウム、70mg/Lストレプトマイシン硫
酸塩および70mg/Lベンジルペニシリンカリウムを
添加して調製する。 (2)分化誘導培地:DMEM培地(IBC Biom
edicals社製)13.48gに蒸留水1L加え、
それぞれ終濃度10容量%CS(CALF BOVIN
E SERUM)、10μg/mLインシュリン、0.
5mmol/L1−メチル−3−イソブチルキサンチン
(MIX)、0.25μmol/Lデキサメサゾン(D
EX)、0.1重量%炭酸水素ナトリウム、70mg/
Lストレプトマイシン硫酸塩および70mg/Lベンジ
ルペニシリンカリウムを添加して調製する。
2. First, (1) DMEM medium containing 10% by volume of CS, (2)
Prepare a differentiation induction medium. (1) DMEM medium containing 10% by volume CS: 13.48 g of DMEM medium (manufactured by IBC Biomedicals)
, 1 L of distilled water was added, and the final concentration was 10% by volume CS (C
ALF BOVINE SERUM), 0.1 wt% sodium bicarbonate, 70 mg / L streptomycin sulfate and 70 mg / L potassium benzylpenicillin. (2) Differentiation induction medium: DMEM medium (IBC Biom)
1L of distilled water to 13.48 g)
Each with a final concentration of 10% by volume CS (CALF BOVIN
E SERUM), 10 μg / mL insulin, 0.
5 mmol / L 1-methyl-3-isobutylxanthine (MIX), 0.25 μmol / L dexamethasone (D
EX), 0.1% by weight sodium bicarbonate, 70 mg /
Prepared by adding L streptomycin sulfate and 70 mg / L potassium benzylpenicillin.

【0031】脂肪細胞前駆細胞株(マウス3T3−L−
1:大日本製薬)を10容量%CS含有DMEM培地培
地にて1×10個/mLに調製し、6穴プレート(I
型コラーゲンコート)に2mLずつ播種して、5%炭酸
ガス、飽和水蒸気下、37℃で培養した。
Adipocyte precursor cell line (mouse 3T3-L-
1: Dainippon Pharmaceutical Co., Ltd.) was adjusted to 1 × 10 5 cells / mL in a DMEM medium containing 10% by volume of CS, and a 6-well plate (I
2 mL each, and cultured at 37 ° C. under 5% carbon dioxide gas and saturated steam.

【0032】各試料(純分約1重量%)を、10容量%
CS含有DMEM培地で希釈して1容量%供試料添加溶
液(純分約0.1mg/mL)とした。なお、ブランク
として10容量%CS含有DMEM培地、陽性対照とし
てβ−エストラジオール、比較対照としてダイズおよび
カッコン抽出物を試験に供した。
Each sample (about 1% by weight of pure content) was added to 10% by volume.
The mixture was diluted with a CS-containing DMEM medium to give a 1% by volume sample-supplemented solution (about 0.1 mg / mL pure). In addition, a DMEM medium containing 10% by volume of CS as a blank, β-estradiol as a positive control, and soybean and cuckoo extracts as comparative controls were subjected to the test.

【0033】Confiuent(約3日)後、培養液
を吸引除去し、PBS(−)で細胞を1回洗浄した後、
分化誘導培地1.8mL、各供試料添加溶液0.2mL
を加え、2日間分化誘導/培養した。
After confient (about 3 days), the culture medium was removed by suction, and the cells were washed once with PBS (-).
1.8 mL of differentiation induction medium, 0.2 mL of each sample added solution
Was added, and differentiation induction / culture was performed for 2 days.

【0034】2日間の分化誘導/培養後、培養液を吸引
除去し、PBS(−)で細胞を1回洗浄する。次に、
0.25重量%トリプシン溶液で脂肪細胞を剥離し、上
清を取り除いた後、PBS(−)で脂肪細胞を回収して
試験液を得た。
After 2 days of differentiation induction / culture, the culture solution is removed by suction, and the cells are washed once with PBS (-). next,
The fat cells were detached with a 0.25% by weight trypsin solution, the supernatant was removed, and then the fat cells were collected with PBS (-) to obtain a test solution.

【0035】試験液にイソプロパノールを加えて混合
後、類似呈色を示すリン脂質、糖および遊離グリセリン
を吸着剤(活性アルミナ)に吸着させ、遠心分離し、上
清のトリグリセライドを得る。次いでトリグリセライド
に5%水酸化カリウムを加えけん化させ、グリセリンを
遊離させた後、緩衝液(2.4mol/L酢酸アンモニ
ウム緩衝液(pH5.5),11重量%イソプロパノー
ル)を加えpHを6にし、50mmol/Lメタ過ヨウ
素酸ナトリウム液でグリセリンを酸化させる。この結
果、グリセリンから1分子のギ酸と2分子のホルムアル
デヒドが生成される。生成したホルムアルデヒドはアセ
チルアセトンおよび緩衝液中のアンモニアと反応して環
状化合物(3,5−ジアセチル−1,4−ジヒドロルチ
ジン)を生じ、410nmに吸収極大をもつ黄色溶液
(測定液)となる。
After isopropanol is added to the test solution and mixed, phospholipids, sugars and free glycerin exhibiting a similar color are adsorbed on an adsorbent (activated alumina) and centrifuged to obtain triglyceride as a supernatant. Next, 5% potassium hydroxide was added to the triglyceride to saponify it, and glycerin was released. Then, a buffer solution (2.4 mol / L ammonium acetate buffer (pH 5.5), 11% by weight isopropanol) was added to adjust the pH to 6, and Glycerin is oxidized with a 50 mmol / L sodium metaperiodate solution. As a result, one molecule of formic acid and two molecules of formaldehyde are produced from glycerin. The formed formaldehyde reacts with acetylacetone and ammonia in the buffer to form a cyclic compound (3,5-diacetyl-1,4-dihydrolutidine), which becomes a yellow solution (measurement solution) having an absorption maximum at 410 nm.

【0036】96穴マイクロプレートに測定液を移し、
プレートリーダー:410nmにおける試料の吸光度
(Es)およびブランクの吸光度(Eb)を測定した。
この発明にかかる各植物の各種抽出物の脂肪合成促進効
果は、数1により脂肪合成促進率(%)を算出して表し
た。結果は表1に示した。
Transfer the measurement solution to a 96-well microplate,
Plate reader: The absorbance of the sample at 410 nm (Es) and the absorbance of the blank (Eb) were measured.
The fat synthesis promoting effect of the various extracts of each plant according to the present invention was calculated by calculating the fat synthesis promoting rate (%) according to Equation 1. The results are shown in Table 1.

【0037】[0037]

【数1】 (Equation 1)

【0038】[0038]

【表1】 [Table 1]

【0039】これらの結果より、本発明にかかる各植物
の各種抽出物に脂肪合成促進効果が認められる。
From these results, various extracts of each plant according to the present invention have an effect of promoting fat synthesis.

【0040】3.化粧料の処方例 本発明にかかる各植物の各種抽出物を用いて、本発明に
かかる化粧料を作成した。なお、配合割合は重量部であ
る。
3. Example of Formulation of Cosmetic The cosmetic according to the present invention was prepared using various extracts of each plant according to the present invention. The mixing ratio is part by weight.

【0041】(1)処方例1(化粧水) 〔製法〕前記原料を精製水に加え均一に混合する。(1) Formulation Example 1 (Lotion) [Production method] The raw materials are added to purified water and mixed uniformly.

【0042】(2)処方例2(化粧用クリーム) 〔製法〕前記水相の原料を混合し、加熱して70℃に保
ち水相部とする。一方、油相の原料を混合し、加熱溶解
して70℃として油相部とする。この油相部を前述の水
相部に加えて予備乳化を行ない、ホモミキサー均一に乳
化し、30℃まで冷却し化粧用クリームを得る。
(2) Formulation example 2 (cosmetic cream) [Manufacturing method] The raw materials for the aqueous phase are mixed and heated to 70 ° C. to form an aqueous phase. On the other hand, the raw materials of the oil phase are mixed and dissolved by heating to 70 ° C. to obtain an oil phase portion. This oil phase is added to the above-mentioned aqueous phase to carry out preliminary emulsification, homogenize uniformly with a homomixer, and cool to 30 ° C. to obtain a cosmetic cream.

【0043】(3)処方例3(化粧用乳液) 〔製法〕前記水相の原料を混合し、加熱して70℃に保
ち水相部とする。一方、他の原料を混合し、加熱溶解し
て70℃として油相部とする。この油相部を前述の水相
部に加えて乳化し、30℃まで冷却し化粧用乳液を得
る。
(3) Formulation example 3 (cosmetic emulsion) [Manufacturing method] The raw materials for the aqueous phase are mixed and heated to 70 ° C. to form an aqueous phase. On the other hand, other raw materials are mixed and dissolved by heating to 70 ° C. to obtain an oil phase. This oil phase is added to the above-mentioned aqueous phase and emulsified, and cooled to 30 ° C. to obtain a cosmetic emulsion.

【0044】(4)処方例4(パック剤) 〔製法〕水相の原料を混合し、均一にする。さらに他の
原料を混合し、均一になるまで攪拌してパック剤を得
る。
(4) Formulation Example 4 (Packing agent) [Production method] The raw materials of the aqueous phase are mixed and made uniform. Further, other raw materials are mixed and stirred until the mixture becomes uniform to obtain a pack.

【0045】(5)処方例5(クリーム状ファンデーシ
ョン) 〔製法〕油相の一部と粉体を3本ロールミルにかけ、残
りの油相を加え加熱溶解させ、80℃に保つ。次に、加
熱溶解した水相を徐々に加えて80℃で乳化し、これを
攪拌しながら室温まで冷却して、クリーム状ファンデー
ションを得る。
(5) Formulation Example 5 (creamy foundation) [Production method] A part of the oil phase and the powder are put on a three-roll mill, and the remaining oil phase is added and dissolved by heating, and kept at 80 ° C. Next, the aqueous phase dissolved by heating is gradually added, and the mixture is emulsified at 80 ° C., and cooled to room temperature with stirring to obtain a creamy foundation.

【0046】4.化粧料の効果試験例 さらに、本発明にかかる化粧料を用いて、実際に使用し
た場合の効果について検討を行った。
4. Example of Effect Test of Cosmetic Further, the effect of the cosmetic according to the present invention when actually used was examined.

【0047】処方例2のラタニィ(Krameria
triandra Ruiz etPar.)抽出物を
含有する化粧用クリームについて、女性らしい「ふっく
ら」した輪郭の形成、乳房の豊胸を望む16〜30歳の
20名をパネラーとし、1ヶ月間毎日、朝と夜の2回、
顔面および乳房全体に塗布してもらい、使用テストを実
施した。対照には、ラタニィ(Krameriatri
andra Ruiz et Par.)抽出物を除い
たプラセボクリームを同様な方法にて処方したものを用
いた。また、評価方法は、下記の基準で、実感面を評価
してもらった。結果は表2のごとくで、表中の数値は人
数を表す。なお、使用期間中に皮膚の異常を訴えた者は
なかった。
The rattany (Krameria) of Formulation Example 2
triandra Ruiz et Par. ) About the cosmetic cream containing the extract, 20 people of 16-30 years old who want to form a feminine "fluffy" outline and breast augmentation are panelists, twice a day every morning for 1 month,
It was applied to the face and the whole breast, and a use test was performed. Controls include rattanii (Krameriatori).
andra Ruiz et Par. ) A placebo cream excluding the extract was formulated in the same manner. In addition, the evaluation method was evaluated based on the following criteria. The results are as shown in Table 2, and the numbers in the table represent the number of people. No one complained of skin abnormalities during the use period.

【0048】〔評価基準〕 有効:明らかに女性らしい「ふっくら」した輪郭の形
成、乳房の豊胸を実感することができた。やや有効:や
や女性らしい「ふっくら」した輪郭の形成、乳房の豊胸
を実感することができた。無効:使用前と変化なし。
[Evaluation Criteria] Effective: Clearly feminine “fluffy” contour formation and breast augmentation could be felt. Slightly effective: I was able to feel the formation of a "fluffy" contour that was somewhat feminine and breast augmentation. Invalid: No change from before use.

【0049】[0049]

【表2】女性らしい「ふっくら」した輪郭の形成効果 [Table 2] Forming effect of feminine "fluffy" contour

【表3】乳房の豊胸効果 [Table 3] Breast augmentation effect of breast

【0051】上記の結果より、本発明にかかる化粧料に
女性らしい「ふっくら」した輪郭の形成、乳房の豊胸効
果が認められる。
From the above results, it can be seen that the cosmetic according to the present invention has a feminine “fluffy” contour formation and a breast augmentation effect.

【0052】[0052]

【発明の効果】各植物の各種抽出物が有する脂肪合成促
進効果に基づいた、優れた脂肪合成促進剤および化粧料
が提供できる。しかも、前記脂肪合成促進剤は、各植物
の各種抽出物に含まれる天然物であるため、副作用も少
なく安全で、しかも熱などに安定であり、前記化粧料の
化粧品分野はもとより医薬品および食品等々の各種技術
分野にも広く途を拓くなど、発明の目的を達成する顕著
な効果を奏することが期待できる。
As described above, it is possible to provide an excellent fat synthesis promoter and cosmetic based on the fat synthesis promoting effect of various extracts of each plant. Moreover, since the fat synthesis promoter is a natural product contained in various extracts of each plant, it is safe with little side effects and is stable to heat and the like. It can be expected that a remarkable effect to achieve the object of the invention will be achieved, such as opening up a wide range of technical fields.

───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 4C083 AA082 AA111 AA112 AA122 AB032 AB242 AB432 AC012 AC022 AC072 AC102 AC122 AC182 AC242 AC422 AC442 AD092 AD112  ──────────────────────────────────────────────────続 き Continued on the front page F term (reference) 4C083 AA082 AA111 AA112 AA122 AB032 AB242 AB432 AC012 AC022 AC072 AC102 AC122 AC182 AC242 AC422 AC442 AD092 AD112

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 カワカワ(Piper methyst
icum Forst.)、クマツヅラ(Verben
a officinalis L.)、コハコベ(St
ellaria media(L.)Vill.)、セ
イヨウタンポポ(Taraxacum officin
ale Weber,Taraxacum sect.
Ruderalia species)、セイヨウナツ
ユキソウ(Filipendura ulmaria
(L.)Maxim.)、ヒマワリ(Helianth
us annuus L.)、マヨラナ(Origan
um majorana L.)、ムラサキツメクサ
(Trifolium pratense L.)、ラ
タニィ(Krameria triandra Rui
z et Par.)、ラレア(Larrea tri
dentata,Larrea mexicana)か
ら選択される1種又は2種以上の植物の抽出物を含有し
てなる脂肪合成促進剤。
1. Kawakawa (Piper method)
icum Forst. ), Kumatsudura (Verben)
a officinalis L .; ), Kohakobe (St
ellaria media (L.) Vill. ), Taraxacum officin
ale Weber, Taraxacum sec.
Ruderalia species), Filippodia ulmaria
(L.) Maxim. ), Sunflower (Helianth)
us annuus L. ), Majorana (Origan)
um majorana L. ), Trifolium platenense L., Ratani (Krameria triandra Rui)
z et Par. ), Larrea tri
A fat synthesis promoter comprising one or more plant extracts selected from dentata, Larrea mexicana).
【請求項2】 カワカワ(Piper methyst
icum Forst.)、クマツヅラ(Verben
a officinalis L.)、コハコベ(St
ellaria media(L.)Vill.)、セ
イヨウタンポポ(Taraxacum officin
ale Weber,Taraxacum sect.
Ruderalia species)、セイヨウナツ
ユキソウ(Filipendura ulmaria
(L.)Maxim.)、ヒマワリ(Helianth
us annuus L.)、マヨラナ(Origan
um majorana L.)、ムラサキツメクサ
(Trifolium pratense L.)、ラ
タニィ(Krameria triandra Rui
z et Par.)、ラレア(Larrea tri
dentata,Larrea mexicana)か
ら選択される1種又は2種以上の植物の抽出物を含有し
てなる化粧料。
2. Kawakawa (Piper method)
icum Forst. ), Kumatsudura (Verben)
a officinalis L .; ), Kohakobe (St
ellaria media (L.) Vill. ), Taraxacum officin
ale Weber, Taraxacum sec.
Ruderalia species), Filippodia ulmaria
(L.) Maxim. ), Sunflower (Helianth)
us annuus L. ), Majorana (Origan)
um majorana L. ), Trifolium platenense L., Ratani (Krameria triandra Rui)
z et Par. ), Larrea tri
A cosmetic comprising one or more plant extracts selected from dentata, Larrea mexicana).
JP2001137981A 2001-03-30 2001-03-30 Fat synthesis accelerator and cosmetics Expired - Lifetime JP4611565B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001137981A JP4611565B2 (en) 2001-03-30 2001-03-30 Fat synthesis accelerator and cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001137981A JP4611565B2 (en) 2001-03-30 2001-03-30 Fat synthesis accelerator and cosmetics

Publications (3)

Publication Number Publication Date
JP2002302416A true JP2002302416A (en) 2002-10-18
JP2002302416A5 JP2002302416A5 (en) 2006-01-05
JP4611565B2 JP4611565B2 (en) 2011-01-12

Family

ID=18984992

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001137981A Expired - Lifetime JP4611565B2 (en) 2001-03-30 2001-03-30 Fat synthesis accelerator and cosmetics

Country Status (1)

Country Link
JP (1) JP4611565B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005187431A (en) * 2003-12-26 2005-07-14 Shiseido Co Ltd Fat accumulation promoting composition
KR101296153B1 (en) 2011-06-10 2013-08-20 (주)제주사랑농수산 Cosmetic composition for pore-minimizing using scoria

Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61178908A (en) * 1984-02-27 1986-08-11 Kanebo Ltd Skin cosmetic
JPH0482837A (en) * 1990-07-26 1992-03-16 Indena Spa Neolignan deriuative and phospholipid composite, method of its use and pharmaceutical and cosmetic preparation containing said composite
JPH05229930A (en) * 1992-02-19 1993-09-07 Kanebo Ltd Skin-whitening cosmetic
JPH0812565A (en) * 1994-06-29 1996-01-16 Shiseido Co Ltd Skin external preparation
JPH08175957A (en) * 1994-12-27 1996-07-09 Kao Corp Skin agent for external use
JPH08245410A (en) * 1995-03-10 1996-09-24 Kao Corp Lipolysis promoter
JPH09291038A (en) * 1995-12-12 1997-11-11 Ennagram Sarl Mixture of plant extract including treatment of local part of symptom of local excessive skinfold thickness and its use
JPH1036279A (en) * 1996-07-18 1998-02-10 Ichimaru Pharcos Co Ltd Fibroblast proliferation promoting agent containing vegetable extract
JPH10276717A (en) * 1997-04-11 1998-10-20 Kiyaratsutsu Internatl:Kk Production of food for making woman bosomy
JPH11189541A (en) * 1997-12-26 1999-07-13 Eag Kk Therapeutic agent for melanogenetic insufficiency
JPH11292898A (en) * 1998-03-15 1999-10-26 Protein Technol Internatl Inc Isoflavone-deficient vegetable protein and vegetable protein composition containing isoflavone-containing material
JP2000154113A (en) * 1998-11-18 2000-06-06 Ichimaru Pharcos Co Ltd Cosmetic composition containing moisturizing plant extract
JP2000507609A (en) * 1996-10-17 2000-06-20 インデナ エッセ.ペ.ア. Drugs with antibacterial activity and cosmetic preparations
JP2000507958A (en) * 1996-10-17 2000-06-27 インデナ エッセ.ペ.ア. Drugs and cosmetic preparations with anti-acne activity
JP2000302667A (en) * 1999-04-23 2000-10-31 Kobe Tennenbutsu Kagaku Kk Accelerator for ample breasts
JP2002503257A (en) * 1998-02-27 2002-01-29 ブロック ドラッグ カンパニー インコーポレイテッド Stable herbal toothpaste

Patent Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61178908A (en) * 1984-02-27 1986-08-11 Kanebo Ltd Skin cosmetic
JPH0482837A (en) * 1990-07-26 1992-03-16 Indena Spa Neolignan deriuative and phospholipid composite, method of its use and pharmaceutical and cosmetic preparation containing said composite
JPH05229930A (en) * 1992-02-19 1993-09-07 Kanebo Ltd Skin-whitening cosmetic
JPH0812565A (en) * 1994-06-29 1996-01-16 Shiseido Co Ltd Skin external preparation
JPH08175957A (en) * 1994-12-27 1996-07-09 Kao Corp Skin agent for external use
JPH08245410A (en) * 1995-03-10 1996-09-24 Kao Corp Lipolysis promoter
JPH09291038A (en) * 1995-12-12 1997-11-11 Ennagram Sarl Mixture of plant extract including treatment of local part of symptom of local excessive skinfold thickness and its use
JPH1036279A (en) * 1996-07-18 1998-02-10 Ichimaru Pharcos Co Ltd Fibroblast proliferation promoting agent containing vegetable extract
JP2000507609A (en) * 1996-10-17 2000-06-20 インデナ エッセ.ペ.ア. Drugs with antibacterial activity and cosmetic preparations
JP2000507958A (en) * 1996-10-17 2000-06-27 インデナ エッセ.ペ.ア. Drugs and cosmetic preparations with anti-acne activity
JPH10276717A (en) * 1997-04-11 1998-10-20 Kiyaratsutsu Internatl:Kk Production of food for making woman bosomy
JPH11189541A (en) * 1997-12-26 1999-07-13 Eag Kk Therapeutic agent for melanogenetic insufficiency
JP2002503257A (en) * 1998-02-27 2002-01-29 ブロック ドラッグ カンパニー インコーポレイテッド Stable herbal toothpaste
JPH11292898A (en) * 1998-03-15 1999-10-26 Protein Technol Internatl Inc Isoflavone-deficient vegetable protein and vegetable protein composition containing isoflavone-containing material
JP2000154113A (en) * 1998-11-18 2000-06-06 Ichimaru Pharcos Co Ltd Cosmetic composition containing moisturizing plant extract
JP2000302667A (en) * 1999-04-23 2000-10-31 Kobe Tennenbutsu Kagaku Kk Accelerator for ample breasts

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005187431A (en) * 2003-12-26 2005-07-14 Shiseido Co Ltd Fat accumulation promoting composition
KR101296153B1 (en) 2011-06-10 2013-08-20 (주)제주사랑농수산 Cosmetic composition for pore-minimizing using scoria

Also Published As

Publication number Publication date
JP4611565B2 (en) 2011-01-12

Similar Documents

Publication Publication Date Title
CN101765432A (en) The deglycation of AGE
EP1003538B1 (en) Use of polygonatum extracts for stimulating dermal elastin synthesis
CN110123684A (en) A kind of hair follicle former base tax liquid living and preparation method thereof with anticreep, hair regrowth
KR102369387B1 (en) Cosmetic Composition for prevention of depilation or improvement of hair growth
KR20140145278A (en) Cosmetic composition containing Cimicifuga heracleifolia extract, Cornus officinalis extract and Geranium nepalense extract for skin convergence and elasticity effect
JP2000239146A (en) Cosmetic
JP2008184441A (en) External preparation for skin for promoting fibroblast proliferation
KR20160003918A (en) Cosmetic composition for enhancing skin elasticity or improving skin wrinkle containing herb extracts
KR102451720B1 (en) Cosmetic compositions comprising multi functional composition containing extract of scutellaria baicalensis, rosmarinus officinalis, houttuynia cordata, artemisia capillaris thunb and calendula officinalis having skin soothing, suppressing sebum, itching relieving or skin moisturizing effect and manufacturing methods thereof
JP4611565B2 (en) Fat synthesis accelerator and cosmetics
TWI706792B (en) Use of skunk cabbage extract or its fraction
KR20170137436A (en) Composition for improving skin condition comprising herb extracts mixture
KR20170136919A (en) Composition for improving skin condition comprising herb extracts mixture
KR101154501B1 (en) A composition of eliminating keratin comprising saussurea involucratae extract
JP4585227B2 (en) Slimming kit
CN108815076A (en) A kind of whitening skin-protection cream and preparation method thereof
KR20200073584A (en) Cosmetic composition for alleviating acne containing effective ingredient of rhododendron brachycarpum and perillafrutescens leaffor
KR20200058730A (en) A composition for preventing hair loss or promoting hair growth
KR102599295B1 (en) A cosmetic composition for skin wrinkle improvement containing mixed extracts of Hojanggeun, Bogolji and Mulberry leaf as an active ingredient
KR102233707B1 (en) Cosmetic composition comprising natural extract and natural powder
KR102533237B1 (en) Cosmetic composition containing complex medicinal herbs extract for improving condition of hair and preventing hair loss
KR102292114B1 (en) Composition for Improving Skin Conditions Having Moisturizing, Anti-Inflammatory Caused by Fine Dust and Pore Shrinkage Property Comprising Plant Complex Extracts as Active Ingredient
KR102635645B1 (en) A hair care composition comprising the natural plant mixture
JP2018002703A (en) Psoriasin production promoter
TWI746917B (en) Use of citrus aurantium flower extract for reducing skin aging and fat content

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051114

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080229

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20100617

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100629

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100830

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20101012

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20101014

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131022

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4611565

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term